Finoriq research workspace
ADIAL PHARMACEUTICALS, INC. (ADIL) SEC Filings & Filing Highlights
Review SEC filings, SEC-derived company events, filing highlights, source excerpts, and material disclosure activity for ADIAL PHARMACEUTICALS, INC. (ADIL).
Company Snapshot
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.
- Company
- ADIAL PHARMACEUTICALS, INC. (ADIL)
- Ticker
- ADIL
- Market Cap
- $5.9M
- Latest Price
- $2.73
- Industry
- Biotech & Pharma
ADIAL PHARMACEUTICALS, INC. (ADIL) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for ADIAL PHARMACEUTICALS, INC. (ADIL).
| Event | Form | Date |
|---|---|---|
| Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financi...Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing | 8-K7.01 | 2026-06-11 |
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K5.03 | 2026-06-11 |
| Director Fees On June 11, 2026, upon closing of the Merger, each director of the Company immedi...Director Fees On June 11, 2026, upon closing of the Merger, each director of the Company immediately prior to the First Effective Time will... | 8-K5.02 | 2026-06-11 |
| ADIAL PHARMACEUTICALS, INC.: Securities issuanceThe information contained in Item 1.01 of this Current Report with respect to the sale and issuance of the 437,474 shares of Common Stock i... | 8-K3.02 | 2026-06-11 |
| Agreement and Plan of MergerOn June 11, 2026, Adial Pharmaceuticals, Inc., a Delaware corporation (the “Company” or “Adial”), acquired Azora Therapeutics, Inc., a Dela... | 8-K1.01 | 2026-06-11 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.